Volume 26, Number 9—September 2020
Synopsis
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020
Benjamin D. Hallowell1, Christina M. Carlson, Jesica R. Jacobs, Mary Pomeroy, Jonathan Steinberg, Mark W. Tenforde, Emily McDonald, Loretta Foster, Leora R. Feldstein, Melissa A. Rolfes, Amber Haynes, Glen R. Abedi, George S. Odongo, Kim Saruwatari, Errin C. Rider, Gina Douville, Neenaben Bhakta, Panagiotis Maniatis, Stephen Lindstrom, Natalie J. Thornburg, Xiaoyan Lu, Brett L. Whitaker, Shifaq Kamili, Senthilkumar K. Sakthivel, Lijuan Wang, Lakshmi Malapati, Janna R. Murray, Brian Lynch, Martin Cetron, Clive Brown, Shahrokh Roohi, Lisa Rotz, Denise Borntrager, Kenta Ishii, Kathleen Moser, Mohammad Rasheed, Brandi Freeman, Sandra Lester, Kizzmekia S. Corbett, Olubukola M. Abiona, Geoffrey B. Hutchinson, Barney S. Graham, Nicki Pesik, Barbara Mahon, Christopher Braden, Casey Barton Behravesh, Rebekah Stewart, Nancy Knight, Aron J. Hall, and Marie E. Killerby
Table 2
Potential exposures to severe acute respiratory syndrome coronavirus 2 by 193 evacuees returning from Wuhan, China, to the United States, January 2020*
| Exposure risk factors | No./total no. (%)† |
|---|---|
| Relevant exposures for serology results‡ | |
| Animal contact | |
| Visited the Huanan Seafood Market in past 2 mo | 1/186 (1) |
| Visited any live animal market in past 2 mo | 9/186 (5) |
| Visited any settings with domesticated animals in past 2 mo | 39/186 (21) |
| Visited any settings with nondomesticated animals in past 2 mo | 8/186 (4) |
| Had direct contact with any animals in past 2 mo | 52/186 (28) |
| Human contact | |
| Had close contact with laboratory-confirmed COVID-19 case-patient in past 2 mo | 1/186 (1) |
| Had close contact with person with fever and/or acute respiratory illness in past 2 mo | 30/186 (16) |
| High-risk settings | |
| Visited a healthcare setting (not in United States) in past 2 mo | 8/186 (4) |
| Worked in a healthcare setting in Wuhan in past 2 mo | 0/186 (0) |
| Worked in a laboratory setting in Wuhan in past 2 mo | 0/186 (0) |
| Travel | |
| Did not travel outside of Hubei Province, China, in past 2 mo |
62/186 (33) |
| Relevant exposures for PCR results§ | |
| Animal contact | |
| Visited any live animal market in past 2 wk | 1/191 (1) |
| Visited any settings with domesticated animals in past 2 wk | 15/191 (8) |
| Visited any settings with nondomesticated animals in past 2 wk | 6/191 (3) |
| Had direct physical contact with live domestic animals in past 2 wk | 36/191 (19) |
| Had direct physical contact with live nondomestic animals in past 2 wk | 2/191 (1) |
| Human contact | |
| Had close contact with laboratory-confirmed COVID-19 case-patient in past 2 wk | 1/191 (1) |
| Had close contact with person with fever and/or acute respiratory illness in past 2 wk | 12/191 (6) |
| High-risk settings | |
| Visited a healthcare setting (not in United States) in past 2 wk | 7/191 (4) |
*COVID-19, coronavirus disease.
†Data for persons for whom responses were missing were excluded from the denominator.
‡Limited to exposures within the past 2 mo and to persons who submitted serum sample.
§Limited to exposures within the past 2 wk and to persons who submitted a nasopharyngeal and/or oropharyngeal swab specimen.
Page created: May 27, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.